42134 Long-term Efficacy of Guselkumab (GUS) on Fatigue and Identification of Early Treatment Targets: Post Hoc Analysis Through 2 Years of a Phase 3, Randomized, Double-blind, Placebo-controlled Study in Biologic-naïve Patients With Psoriatic Arthritis (PsA)

    September 2023 in “ Journal of the American Academy of Dermatology ”
    Dafna D. Gladman, Michael Starr, Roberto Ranza, Ana-Maria Bravo Perdomo, Marcie Strauss, M. Shawi, Chenglong Han

    We don't know much about this study yet.

    We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.
    Discuss this study in the Community →